$94.97
0.00 (0%)
Genentech, Inc. (NYSE:DNA.DL)
CAPS Rating:
The Company is a biotechnology company that discovers, develops, manufactures, and commercializes biotherapeutics for unmet medical needs.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
No players have picked DNA.DL yet. Tell us why you think DNA.DL will outperform or underperform the market.
RSS Headlines
Fool UK
